Cranial aspergillosis in a patient receiving ibrutinib for chronic lymphocytic leukemia

被引：10
|
作者：
Beresford, Rohan [1 ]
Dolot, Virginia [1 ]
Foo, Hong [1 ,2 ]
机构：
[1] NSW Hlth Pathol South West Sydney, Dept Microbiol & Infect Dis, Sydney, NSW, Australia
[2] Western Sydney Univ, Sch Med, Campbelltown, NSW, Australia
来源：
MEDICAL MYCOLOGY CASE REPORTS | 2019年 / 24卷
关键词：
Aspergillosis; Ibrutinib; Cerebral abscess; Chronic lymphocytic leukemia;
D O I：
10.1016/j.mmcr.2019.02.005
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
Cerebral abscess due to Aspergillus species is a relatively uncommon presentation, even amongst immunocompromised patients. However it is increasingly being recognized as a complication of ibrutinib therapy in patients with chronic lymphocytic leukemia. We present a case of cerebral abscesses caused by Aspergillus felis in a patient receiving ibrutinib for chronic lymphocytic leukemia.
引用
收藏
页码：27 / 29
页数：3
相关论文
共 50 条
  • [21] Ibrutinib treatment of a patient with relapsing chronic lymphocytic leukemia and sustained remission of Richter syndrome
    Albi, Elisa
    Baldoni, Stefano
    Aureli, Patrizia
    Dorillo, Erica
    Del Papa, Beatrice
    Ascani, Stefano
    Di Ianni, Mauro
    Falzetti, Franca
    Sportoletti, Paolo
    TUMORI, 2017, 103 : S37 - S40
  • [22] Hepatitis B Virus Reactivation under Ibrutinib Treatment in a Patient with Chronic Lymphocytic Leukemia
    Iskender, Gulsen
    Iskender, Dicle
    Ertek, Mustafa
    TURKISH JOURNAL OF HEMATOLOGY, 2020, 37 (03) : 208 - 209
  • [23] Ibrutinib (PCI-32765) in Chronic Lymphocytic Leukemia
    Jain, Nitin
    O'Brien, Susan
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2013, 27 (04) : 851 - +
  • [24] Sequential disseminated aspergillosis and pulmonary tuberculosis in a patient treated by idelalisib for chronic lymphocytic leukemia
    Lafon-Desmurs, B.
    Monsel, G.
    Leblond, V.
    Papo, M.
    Caumes, E.
    Fekkar, A.
    Jaureguiberry, S.
    MEDECINE ET MALADIES INFECTIEUSES, 2017, 47 (04): : 293 - 296
  • [25] Spuriously low lymphocyte count associated with pseudoerythroblastemia in a patient with chronic lymphocytic leukemia treated with ibrutinib
    Robier, Christoph
    Beham-Schmid, Christine
    Neubauer, Manfred
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (05) : E112 - E114
  • [26] Malakoplakia of the Urinary Bladder in a Patient with Chronic Lymphocytic Leukemia Under Ibrutinib Therapy: A Case Report
    Sachanas, Sotirios
    Pangalis, Gerassimos A.
    Karouzakis, Petros
    Koulieris, Efstathios
    Moschogiannis, Maria
    Kalpadakis, Christina
    Yiakoumis, Xanthi
    Rontogianni, Dimitra
    ANTICANCER RESEARCH, 2016, 36 (09) : 4759 - 4762
  • [27] Cytomegalovirus Proctitis in a Patient with Chronic Lymphocytic Leukemia on Ibrutinib Therapy: A Case Report
    Reddy, Yeshaswini
    Baig, Muhammad
    Kalva, Nikhil
    Puli, Srinivas
    Dhillon, Sonu
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (04)
  • [28] Ibrutinib and its use in the treatment o chronic lymphocytic leukemia
    Frustaci, Anna Maria
    Tedeschi, Alessandra
    Deodato, Marina
    Mazzucchelli, Maddalena
    Cairoli, Roberto
    Montillo, Marco
    FUTURE ONCOLOGY, 2018, 14 (08) : 681 - 697
  • [29] IBRUTINIB FOR THE TREATMENT OF CHRONIC LYMPHOCYTIC LEUKEMIA AND MANTLE CELL LYMPHOMA
    McDermott, J.
    Jimeno, A.
    DRUGS OF TODAY, 2014, 50 (04) : 291 - 300
  • [30] Miliary tuberculosis after initiation of ibrutinib in chronic lymphocytic leukemia
    Song-Yau Wang
    Thomas Ebert
    Nadja Jaekel
    Stefan Schubert
    Dietger Niederwieser
    Haifa Kathrin Al-Ali
    Annals of Hematology, 2015, 94 : 1419 - 1420
12345